Stock News Releases and Press Releases OTCMKTS, NASDAQ and NYSE Markets

The tentpole North American event for electric and hybrid vehicles kicks off registration for first year in Detroit, offering increased accessibility and enhanced expo discoverability. DETROIT, MI / ACCESSWIRE / July 2, 2024 / The Battery Show , North America's largest and most compreh...

NIKOLA WHOLESALES 72 HYDROGEN FUEL CELL TRUCKS FOR NORTH AMERICAN CUSTOMERS IN Q2 2024, EXCEEDS SALES GUIDANCE PR Newswire PHOENIX , July 2, 2024 /PRNewswire/ -- For Q2 2024, Nikola Corporation (Nasdaq: NKLA), a global leader in zero-emissions transportation ...

BOCA RATON, Fla., July 02, 2024 (GLOBE NEWSWIRE) -- Xeriant, Inc. (OTCQB: XERI) (“Xeriant” or “the Company”), a company dedicated to the discovery, development and commercialization of aerospace technologies and advanced materials, provides an update on its plans to sc...

Supplier concludes deal with sixth PAM customer as part of strategic goal of being the leading technology and content supplier to the Dutch market Bragg Gaming Group ( NASDAQ: BRAG , TSX: BRAG ) (“ Bragg ” or the “ Company ”) has launched Ha...

Canadian Investment Regulatory Organization Trading Halt - AD.DB Canada NewsWire TORONTO , July 2, 2024 /CNW/ - The following issues have been halted by CIRO: Company: Alaris Equity Partners Income Trust TSX Symbol: AD.DB All Issues: No Reason: Pendin...

ARLO LAUNCHES STRATEGIC PARTNERSHIP WITH ALLSTATE PR Newswire Industry Leaders with Common Mission to Protect Customers Collaborate to Deliver Added Peace of Mind Through DIY Smart Home Security Solutions SAN JOSE, Calif. , July 2, 2024 /PRNewswire/ -- ...

BERKELEY, Calif. and MAINZ, Germany, July 02, 2024 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ: MYNZ), a molecular genetics diagnostic company specializing in the early detection of cancer, today reviewed its major accomplishments of the first six months ending June 30, 2024, and provided a cor...

WALTHAM, Mass., July 02, 2024 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced it has entered into a definitive agreement with a single healthcare-dedicated institutional in...

WALTHAM, Mass., July 02, 2024 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced it has entered into a definitive agreement with a single healthcare-dedicated institutional in...

2024-07-02 08:00:11 ET Gregory Francfort from Guggenheim issued a price target of $280.00 for MCD on 2024-07-02 07:03:00. The adjusted price target was set to $280.00. At the time of the announcement, MCD was trading at $249.99. The overall price target consensus is at $...